The role of Thr139 in the human immunodeficiency virus type 1 reverse transcriptase sensitivity to (+)-calanolide A

被引:14
|
作者
Auwerx, J
Rodríguez-Barrios, F
Ceccherini-Silberstein, F
San-Félix, A
Velázquez, S
De Clercq, E
Camarasa, MJ
Perno, CF
Gago, F
Balzarini, J
机构
[1] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
[2] Univ Alcala de Henares, Dept Pharmacol, Alcala De Henares, Spain
[3] Univ Roma Tor Vergata, Dept Expt Med, Rome, Italy
[4] CSIC, Inst Quim Med, E-28006 Madrid, Spain
关键词
D O I
10.1124/mol.105.012351
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The coumarins represent a unique class of non-nucleoside reverse transcriptase inhibitors (NNRTIs) that were isolated from tropical plants. (+)-Calanolide A, the most potent compound of this class, selects for the T139I resistance mutation in HIV-1 reverse transcriptase (RT). Seven RTs mutated at amino acid position 139 (Ala, Lys, Tyr, Asp, Ile, Ser, and Gln) were constructed by site-directed mutagenesis. The mutant T139Q enzyme retained full catalytic activity compared with wild-type RT, whereas the mutant T139I, T139S, and T139A RTs retained only 85 to 50% of the activity. Mutant T139K, T139D, and T139Y RTs had seriously impaired catalytic activities. The mutations in the T139I and T139D RTs were shown to destabilize the RT heterodimer. (+)-Calanolide A lost inhibitory activity (up to 20-fold) against the mutant T139Y, T139Q, T139K, and T139I enzymes. All of the mutant enzymes retained marked susceptibility toward the other NNRTIs, including nevirapine, delavirdine, efavirenz, thiocarboxanilide UC-781, quinoxaline GW867420X, TSAO [[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5 ''-(4 ''-amino-1 '',2 ''-oxathiole-2 '',2 ''-dioxide)]derivatives, and the nucleoside inhibitor, ddGTP. The fact that the T139I RT 1) proved to be resistant to (+)-calanolide A, 2) represents a catalytically efficient enzyme, and 3) requires only a single transition point mutation (ACA -> ATA) in codon 139 seems to explain why mutant T139I RT virus strains, but not virus strains containing other amino acid changes at this position, predominantly emerge in cell cultures under (+)-calanolide A pressure.
引用
收藏
页码:652 / 659
页数:8
相关论文
共 50 条
  • [21] Metabolism of the human immunodeficiency virus type 1 reverse transcriptase inhibitor delavirdine in rats
    Chang, M
    Sood, VK
    Wilson, GJ
    Kloosterman, DA
    Sanders, PE
    Hauer, MJ
    Fagerness, PE
    DRUG METABOLISM AND DISPOSITION, 1997, 25 (02) : 228 - 242
  • [22] Eukaryotic expression of enzymatically active human immunodeficiency virus type 1 reverse transcriptase
    Isaguliants, MG
    Pokrovskaya, K
    Kashuba, VI
    Pokholok, D
    Hinkula, J
    Wahren, B
    Kochetkov, SN
    FEBS LETTERS, 1999, 447 (2-3) : 232 - 236
  • [23] Effect of manuka honey on human immunodeficiency virus type 1 reverse transcriptase activity
    Obossou, Etienne Kochole
    Shikamoto, Yasuo
    Hoshino, Yuki
    Kohno, Hayato
    Ishibasi, Yukiko
    Kozasa, Tohru
    Taguchi, Maho
    Sakakibara, Iwao
    Tonooka, Keiko
    Shinozuka, Tatsuo
    Mori, Kazuya
    NATURAL PRODUCT RESEARCH, 2022, 36 (06) : 1552 - 1557
  • [24] Effects of human immunodeficiency virus type 1 resistance to protease inhibitors on reverse transcriptase processing, activity, and drug sensitivity
    de la Carrière, LC
    Paulous, S
    Clavel, F
    Mammano, F
    JOURNAL OF VIROLOGY, 1999, 73 (04) : 3455 - 3459
  • [25] INFECTIOUS POTENTIAL OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 REVERSE-TRANSCRIPTASE MUTANTS WITH ALTERED INHIBITOR SENSITIVITY
    LARDER, BA
    KEMP, SD
    PURIFOY, DJM
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (13) : 4803 - 4807
  • [26] Sensitivity and resistance to (+)-calanolide A of wild-type and mutated forms of HIV-1 reverse transcriptase
    Quan, YD
    Motakis, D
    Buckheit, R
    Xu, ZQ
    Flavin, MT
    Parniak, MA
    Wainberg, MA
    ANTIVIRAL THERAPY, 1999, 4 (04) : 203 - 209
  • [27] Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and moloney murine leukemia virus reverse transcriptase
    Gao, HQ
    Sarafianos, SG
    Arnold, E
    Hughes, SH
    JOURNAL OF MOLECULAR BIOLOGY, 1999, 294 (05) : 1097 - 1113
  • [28] Inhibition of Foamy Virus Reverse Transcriptase by Human Immunodeficiency Virus Type 1 RNase H Inhibitors
    Corona, Angela
    Schneider, Anna
    Schweimer, Kristian
    Roesch, Paul
    Woehrl, Birgitta M.
    Tramontano, Enzo
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (07) : 4086 - 4093
  • [29] The role of steric hindrance in 3TC resistance of human immunodeficiency virus type-1 reverse transcriptase
    Gao, HQ
    Boyer, PL
    Sarafianos, SG
    Arnold, E
    Hughes, SH
    JOURNAL OF MOLECULAR BIOLOGY, 2000, 300 (02) : 403 - 418
  • [30] Role of Vif in human immunodeficiency virus type 1 reverse transcription
    Goncalves, J
    Korin, Y
    Zack, J
    Gabuzda, D
    JOURNAL OF VIROLOGY, 1996, 70 (12) : 8701 - 8709